Lipocine (LPCN) Institutional Ownership → How Biden has already won 2024 (From Porter & Company) (Ad) Free LPCN Stock Alerts $4.85 -0.16 (-3.19%) (As of 05/8/2024 ET) Add Compare Share Share OwnershipStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Lipocine (NASDAQ:LPCN)CurrentInstitutional OwnershipPercentage9.11%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$362.22KNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$3.71M Get LPCN Insider Trade Alerts Want to know when executives and insiders are buying or selling Lipocine stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data LPCN Institutional Buying and Selling by Quarter Ad Huge AlertsThis 1 Biotech Stock has been shocking the marketsSave the Date: BioStem's 2024 Q1 Call Coming Up!Sign Up for the Live Broadcast here Lipocine Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails1/29/2024 Wealth Effects LLC14,639$41K0.0%-22.0%0.275% 10/16/2023 Wealth Effects LLC18,761$56K0.0%-35.9%0.353% 7/18/2023 Wealth Effects LLC29,273$148K0.1%-96.1%0.563% 6/5/2023EP Wealth Advisors LLC66,983$13.40M0.2%N/A1.288% 5/4/2023 Wealth Effects LLC756,674$241K0.1%-35.8%0.855% 2/13/2023 Wealthspan Partners LLC73,950$29K0.0%N/A0.084% Get the Latest News and Ratings for LPCN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Lipocine and its competitors with MarketBeat's FREE daily newsletter. 2/2/2023 Wealth Effects LLC1,178,834$469K0.3%-3.0%1.332% 2/2/2023Bailard Inc.82,957$32K0.0%N/A0.094% 11/7/2022Virtu Financial LLC93,411$42K0.0%N/A0.106% 8/3/2022 Carson Advisory Inc.52,000$42K0.0%N/A0.059% 7/27/2022Bailard Inc.74,400$60K0.0%N/A0.084% 7/22/2022 Aaron Wealth Advisors LLC145,045$116K0.0%+23.4%0.164% 5/13/2022EAM Investors LLC657,804$901K0.2%N/A0.743% 5/10/2022 Aaron Wealth Advisors LLC117,552$85.81M1.2%N/A0.133% 4/26/2022Kestra Advisory Services LLC307,300$421K0.0%+27.9%0.347% 2/14/2022 GSA Capital Partners LLP440,432$437K0.1%+39.7%0.499% 2/9/2022 Wealth Effects LLC1,489,434$1.48M0.6%N/A1.687% 11/15/2021 GSA Capital Partners LLP315,308$344K0.0%+122.8%0.357% 11/10/2021Mercer Global Advisors Inc. ADV313,111$341K0.0%+6.8%0.355% 11/9/2021Barclays PLC24,075$26K0.0%+243.3%0.027% 10/19/2021Kestra Advisory Services LLC249,418$272K0.0%+256.3%0.282% 8/16/2021State Street Corp304,617$426K0.0%+2,356.6%0.345% 8/13/2021Northern Trust Corp173,117$242K0.0%+16.8%0.196% 8/13/2021LPL Financial LLC62,750$88K0.0%+46.8%0.071% 8/13/2021Geode Capital Management LLC760,586$1.06M0.0%+26.0%0.861% 8/13/2021Vanguard Group Inc.3,815,348$5.34M0.0%+6.4%4.321% 8/12/2021XTX Topco Ltd20,706$29K0.0%-30.8%0.023% 8/11/2021 Bank of New York Mellon Corp110,204$154K0.0%+99.6%0.125% 8/11/2021BlackRock Inc.1,582,415$2.22M0.0%-2.5%1.792% 8/10/2021Mercer Global Advisors Inc. ADV293,111$410K0.0%+38.8%0.332% 8/10/2021 Principal Financial Group Inc.20,382$29K0.0%N/A0.023% 8/5/2021 GSA Capital Partners LLP141,521$198K0.0%+12.3%0.160% 5/19/2021Virtu Financial LLC191,387$289K0.0%-8.0%0.217% 5/19/2021Squarepoint Ops LLC84,001$127K0.0%+515.5%0.095% 5/18/2021Cubist Systematic Strategies LLC55,200$83K0.0%N/A0.063% 5/18/2021Jane Street Group LLC29,060$44K0.0%N/A0.033% 5/17/2021Price T Rowe Associates Inc. MD89,264$135K0.0%N/A0.101% 5/17/2021Ameriprise Financial Inc.702,000$1.06M0.0%-4.2%0.795% 5/14/2021MML Investors Services LLC41,000$62K0.0%N/A0.046% 5/14/2021XTX Topco Ltd29,929$45K0.0%N/A0.034% Claim Your Complimentary Bitcoin Reward (Ad)Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.Secure Your Spot Now5/13/2021Barclays PLC21,594$33K0.0%N/A0.024% 5/12/2021Northern Trust Corp148,222$224K0.0%+19.3%0.168% 5/12/2021Geode Capital Management LLC603,713$911K0.0%+33.9%0.684% 5/11/2021Mercer Global Advisors Inc. ADV211,210$319K0.0%-27.5%0.239% 5/10/2021 GSA Capital Partners LLP125,993$190K0.0%-32.3%0.143% 2/24/2021Virtu Financial LLC207,996$283K0.0%N/A0.253% 2/12/2021Mercer Global Advisors Inc. ADV291,210$396K0.0%+20.7%0.355% 2/11/2021Northern Trust Corp124,210$169K0.0%+40.4%0.151% 2/9/2021 Bank of New York Mellon Corp60,886$83K0.0%N/A0.074% 2/5/2021BlackRock Inc.1,618,913$2.20M0.0%+0.5%1.972% 2/4/2021 GSA Capital Partners LLP185,992$253K0.0%+133.0%0.227% 1/20/2021Kestra Advisory Services LLC346,118$453K0.0%N/A0.527% 12/10/2020Mercer Global Advisors Inc. ADV241,210$340K0.0%-11.3%0.367% 11/6/2020BlackRock Inc.1,610,701$2.27M0.0%+122.7%2.452% 11/6/2020 GSA Capital Partners LLP79,817$113K0.0%+32.2%0.122% 8/12/2020Goldman Sachs Group Inc.20,851$26K0.0%N/A0.044% 5/18/2020Mercer Global Advisors Inc. ADV120,348$58K0.0%+71.1%0.251% 5/1/2020BlackRock Inc.805,443$386K0.0%+4.1%1.683% (Data available from 1/1/2016 forward) LPCN Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of LPCN shares? During the previous two years, the following institutional investors and hedge funds held shares of Lipocine shares: EP Wealth Advisors LLC ($13.40M), EAM Investors LLC ($901K), Aaron Wealth Advisors LLC ($116K), Virtu Financial LLC ($42K), Carson Advisory Inc. ($42K), Wealth Effects LLC ($41K), and Bailard Inc. ($32K).Learn more on LPCN's institutional investors. What percentage of Lipocine stock is owned by institutional investors? 9.11% of Lipocine stock is owned by institutional investors. Learn more on LPCN's institutional investor holdings. Which institutional investors have been buying Lipocine stock? The following institutional investors have purchased Lipocine stock in the last 24 months: EAM Investors LLC ($657.80K), Bailard Inc. ($157.36K), Aaron Wealth Advisors LLC ($145.05K), Virtu Financial LLC ($93.41K), Wealthspan Partners LLC ($73.95K), EP Wealth Advisors LLC ($66.98K), and Carson Advisory Inc. ($52K). How much institutional buying is happening at Lipocine? Institutional investors have bought a total of 1,246,550 shares in the last 24 months. This purchase volume represents approximately $22.29M in transactions. Which Lipocine major shareholders have been selling company stock? The following institutional investors have sold Lipocine stock in the last 24 months: Wealth Effects LLC ($1.20M). How much institutional selling is happening at Lipocine? Institutional investors have sold a total of 1,201,195 shares in the last 24 months. This volume of shares sold represents approximately $6.24M in transactions. Related Companies: BFRG Major Shareholders ITRM Major Shareholders SNSE Major Shareholders NRXP Major Shareholders UBX Major Shareholders BIOR Major Shareholders LUMO Major Shareholders FBRX Major Shareholders CPIX Major Shareholders LSTA Major Shareholders This page (NASDAQ:LPCN) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaThis 1 Biotech Stock has been shocking the marketsHuge AlertsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsUrgent Nvidia WarningAltimetry348 million Americans lives to END as we know it?The Oxford ClubThe A.I. story nobody is telling you (Read ASAP)TradeSmith Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lipocine Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
